| Literature DB >> 28588266 |
Virginia M Artegoitia1, Andrew P Foote2, Ronald M Lewis1, Harvey C Freetly3.
Abstract
The rumen has a central role in the efficiency of digestion in ruminants. To identify potential differences in rumen function that lead to differences in average daily gain (ADG), rumen fluid metabolomic analysis by LC-MS and multivariate/univariate statistical analysis were used to identify differences in rumen metabolites. Individual feed intake and body-weight was measured on 144 steers during 105 d on a high concentrate ration. Eight steers with the greatest ADG and 8 steers with the least-ADG with dry matter intake near the population average were selected. Blood and rumen fluid was collected from the 16 steers 26 d before slaughter and at slaughter, respectively. As a result of the metabolomics analysis of rumen fluid, 33 metabolites differed between the ADG groups based on t-test, fold changes and partial least square discriminant analysis. These metabolites were primarily involved in linoleic and alpha-linolenic metabolism (impact-value 1.0 and 0.75, respectively; P < 0.05); both pathways were down-regulated in the greatest-ADG compared with least-ADG group. Ruminal biohydrogenation might be associated with the overall animal production. The fatty acids were quantified in rumen and plasma using targeted MS to validate and evaluate the simple combination of metabolites that effectively predict ADG.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28588266 PMCID: PMC5460109 DOI: 10.1038/s41598-017-02856-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Identification of ruminal fluid metabolites for feed efficiency.
| Metabolites | Formula | Adducts | RT (min) | Ion (m/z) | Mass error (ppm) | ID | Fold change |
|---|---|---|---|---|---|---|---|
| Alloxan | C4H2N2O4 | M−H | 15.87 | 140.99 | 1.97 | BMDB02818 | 1.27 |
| 12,13-DHOME | C18H34O4 | M−H | 10.17 | 313.24 | 1.47 | BMDB04705 | −1.43 |
| Kynurenic acid | C10H7NO3 | M−H | 2.19 | 188.03 | 3.25 | BMDB00715 | −1.96 |
| Tauroursodeoxycholic Acid | C26H45NO6S | M−H | 1.80 | 498.29 | 0.73 | BMDB00874 | −6.74 |
| Celastrol | C29H38O4 | M−H | 12.29 | 449.27 | 2.25 | BMDB02385 | 1.40 |
| DG(22:0/20:3(5Z,8Z,11Z)/0:0) | C45H82O5 | M+H | 14.63 | 703.62 | 3.66 | BMDB07603 | 2.02 |
| Pentadecanoic acid | C15H30O2 | M−H | 13.03 | 241.22 | 1.06 | BMDB00826 | −1.70 |
| Malonyl-L-carnitine | C10H17NO6 | M−H | 1.95 | 246.10 | 0.40 | BMDB02095 | 1.30 |
| Pterin | C6H5N5O | M−H | 13.03 | 162.04 | 2.64 | BMDB00802 | 1.48 |
| N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole | C14H19N2O7P | M+H | 8.67 | 359.09 | 2.19 | BMDB03882 | 1.76 |
| Pteroyl-D-glutamic acid | C20H23N7O7 | M+H | 10.78 | 474.17 | 1.47 | BMDB02140 | 1.17 |
| N-Acryloylglycine | C5H7NO3 | M+H | 12.40 | 130.05 | 4.82 | BMDB01843 | 1.13 |
| Eicosenoic acid2 | C20H38O2 | M−H | 14.59 | 309.28 | 0.99 | BMDB02231 | −1.62 |
| Pyroglutamic acid | C5H7NO3 | M−H | 13.28 | 128.03 | 4.73 | BMDB00267 | 1.62 |
| All-trans-heptaprenyl diphosphate | C28H49N3O16 | M+H | 10.46 | 655.38 | 3.81 | BMDB12187 | −1.51 |
| 5-Dodecenoic acid | C12H22O2 | M+H | 10.35 | 199.17 | 4.97 | BMDB00529 | −1.38 |
| 3-Oxooctadecanoic acid | C18H34O3 | M+H | 10.35 | 299.26 | 2.80 | BMDB10736 | −1.33 |
| Androsterone sulfate | C19H30O5S | M+H | 8.67 | 371.19 | 2.75 | BMDB02759 | 1.23 |
| DG(18:3(9Z,12Z,15Z)/15:0/0:0) | C36H64O5 | M+H | 17.45 | 577.48 | 4.31 | BMDB07300 | 1.43 |
| Linoleic acid | C18H32O2 | M+H | 10.35 | 281.25 | 2.59 | BMDB00673 | −1.21 |
| 20-Carboxyleukotriene B4 | C20H30O6 | M+H | 14.26 | 367.21 | 1.21 | BMDB06059 | −1.14 |
| Harderoporphyrin | C35H36N4O6 | M+H | 12.11 | 609.27 | 3.55 | BMDB00683 | −2.56 |
| Sebacic acid | C10H18O4 | M−H | 7.31 | 201.11 | 2.59 | BMDB00792 | 1.38 |
| Oleamide | C18H35NO | M+H | 15.07 | 282.28 | 3.66 | BMDB02117 | 1.13 |
| Glycocholic acid | C26H43NO6 | M−H | 5.52 | 464.30 | 0.96 | BMDB00138 | −1.94 |
| Chitin | C28H49N3O16 | M+H | 10.57 | 684.32 | 3.56 | BMDB03362 | 1.41 |
| Imidazole-4-Acetaldehyde | C5H6N2O | M−H | 1.36 | 109.04 | 3.19 | BMDB03905 | 1.13 |
| Vaccenic acid | C18H34O2 | M−H | 13.39 | 281.25 | 0.16 | BMDB03231 | −1.37 |
| Calcitroic acid | C23H34O4 | M+H | 11.20 | 375.25 | 2.29 | BMDB06472 | 1.13 |
| Alpha-Linolenic acid | C18H30O2 | M+H | 9.80 | 279.23 | 1.08 | BMDB01388 | −2.23 |
| 12a-Hydroxy-3- | |||||||
| Oxo-choladienic acid | C24H34O4 | M−H | 11.59 | 385.24 | 1.49 | BMDB00385 | −1.35 |
| 5-Sulfosalicylic acid | C7H6O6S | M+H | 13.46 | 219.00 | 1.77 | BMDB11725 | 1.51 |
| 2-Octenedioic acid | C8H12O4 | M−H | 9.52 | 171.07 | 2.13 | BMDB00341 | 1.50 |
| Methylimidazole acetaldehyde | C6H8N2O | M+H | 0.47 | 125.071 | 1.14 | BMDB04181 | 1.13 |
| DG(16:0/20:3(5Z,8Z,11Z)/0:0) | C39H70O5 | M+H | 14.12 | 619.52 | −0.98 | BMDB07110 | −1.09 |
| Taurallocholic acid | C26H45NO7S | M−H | 2.22 | 514.28 | 1.05 | BMDB00922 | −8.30 |
| Glycoursodeoxycholic acid | C26H43NO5 | M−H | 7.39 | 448.30 | −1.25 | BMDB00708 | −2.02 |
| Taurine | C2H7NO3S | M−H | 1.23 | 124.01 | 0.35 | BMDB00251 | −1.45 |
| L-Thyronine | C15H15NO4 | M−H | 1.85 | 272.09 | 1.27 | BMDB00667 | 1.26 |
| 7a,12a-Dihydroxy-3-oxo-4-cholenoic acid | C24H36O5 | M+H | 9.84 | 405.26 | −4.65 | BMDB00447 | −1.09 |
| Pyridinoline | C18H28N4O8 | M+H | 9.37 | 429.20 | 1.44 | BMDB00851 | −1.21 |
| 3-Methoxybenzenepropanoic acid | C10H12O3 | M−H | 1.91 | 179.07 | 1.21 | BMDB11751 | 1.14 |
| 17-Hydroxylinolenic acid | C18H30O3 | M+H | 9.77 | 295.23 | −0.57 | BMDB11108 | −1.12 |
| Stearidonic acid | C18H28O2 | M+H | 8.63 | 277.22 | 1.79 | BMDB06547 | −1.11 |
| 1,25-Dihydroxyvitamin D3-26,23-lactone | C27H40O5 | M−H | 13.39 | 443.28 | 0.55 | BMDB00969 | 1.16 |
| 3-Oxodecanoic acid | C10H18O3 | M−H | 1.88 | 185.12 | −0.94 | BMDB10724 | −1.26 |
| L-Acetylcarnitine | C9H17NO4 | M+H | 3.64 | 204.12 | 1.82 | BMDB00201 | −2.37 |
| Dihydrozeatin-O-glucoside | C16H25N5O6 | M+H | 1.16 | 384.19 | 1.04 | BMDB12214 | 1.35 |
| L-Lactic acid | C3H6O3 | M−H | 0.36 | 89.02 | −0.72 | BMDB00190 | −1.43 |
| Retinoic acid | C20H28O2 | M−H | 1.03 | 299.20 | 2.24 | BMDB01852 | 1.68 |
| 5-Hydroxytryptophol | C10H11NO2 | M−H | 1.35 | 176.07 | 0.27 | BMDB01855 | 1.08 |
| 18-Hydroxycortisol | C21H30O6 | M+H | 13.49 | 379.21 | 4.86 | BMDB00418 | −1.13 |
| Octadecanedioic acid | C18H34O4 | M−H | 10.17 | 313.24 | −1.47 | BMDB00782 | −1.29 |
| Cortisol | C21H30O5 | M+H | 12.98 | 363.22 | −0.48 | BMDB00063 | 1.08 |
| MG(18:0/0:0/0:0) | C21H42O4 | M+H | 11.93 | 359.32 | −0.30 | BMDB11131 | 1.12 |
| Donepezil | C24H29NO3 | M+H | 8.55 | 380.22 | −4.55 | BMDB05041 | −1.11 |
| MG(14:1(9Z)/0:0/0:0) | C17H32O4 | M−H | 13.83 | 299.22 | −4.37 | BMDB11531 | 1.15 |
| L-Glutamic acid 5-phosphate | C5H10NO7P | M−H | 6.36 | 226.01 | −0.56 | BMDB01228 | 1.25 |
| Indole-5,6-quinone | C8H5NO2 | M−H | 1.12 | 146.02 | 2.63 | BMDB06779 | −1.29 |
| PE(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) | C49H80NO8P | M+H | 13.46 | 842.57 | −1.09 | BMDB09603 | 1.10 |
| Deoxypyridinoline | C18H28N4O7 | M+H | 11.01 | 413.20 | −1.82 | BMDB00569 | −1.27 |
| 5-L-Glutamylglycine | C7H12N2O5 | M+H | 0.42 | 205.08 | −0.56 | BMDB11667 | −1.54 |
| MG(P-18:0e/0:0/0:0) | C21H42O3 | M+H | 12.73 | 343.32 | 2.10 | BMDB11153 | 1.25 |
| 5-Hydroxy-N-formylkynurenine | C11H12N2O5 | M−H | 0.65 | 251.07 | −1.15 | BMDB04086 | −1.19 |
| PS(14:0/18:2(9Z,12Z)) | C38H70NO10P | M+H | 14.12 | 732.48 | −4.02 | BMDB12336 | −1.13 |
| 9S-HPODE | C18H32O4 | M−H | 6.94 | 311.22 | −1.54 | BMDB06940 | −1.29 |
| Beta-Cortol | C21H36O5 | M−H | 9.37 | 367.25 | −3.46 | BMDB05821 | −1.61 |
| Arachidic acid | C20H40O2 | M−H | 14.63 | 311.30 | −1.69 | BMDB02212 | −1.28 |
| Ursodeoxycholic acid | C24H40O4 | M−H | 6.44 | 391.28 | 1.98 | BMDB00946 | −1.58 |
| 4alpha-Formyl-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol | C29H46O2 | M+H | 11.26 | 427.36 | 3.55 | BMDB12167 | 1.21 |
| LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) | C28H48NO7P | M+ H | 10.65 | 542.32 | −0.58 | BMDB10397 | −1.18 |
| Cortol | C21H36O5 | M−H | 9.07 | 367.25 | −3.82 | BMDB03180 | −1.79 |
| (R)−3-Hydroxy-hexadecanoic acid | C16H32O3 | M−H | 11.01 | 271.23 | −1.15 | BMDB10734 | −1.19 |
| LysoPC(18:2(9Z,12Z)) | C26H50NO7P | M+H | 10.65 | 520.34 | 2.85 | BMDB10386 | 1.42 |
| Naringenin | C15H12O5 | M−H | 1.13 | 271.06 | 1.25 | BMDB02670 | 1.25 |
| p-Cresol glucuronide | C13H16O7 | M−H | 1.87 | 283.08 | 0.88 | BMDB11686 | 1.71 |
| Ubiquinone | C14H18O4 | M−H | 3.40 | 249.11 | −1.39 | BMDB02012 | 1.09 |
| Indoleacetaldehyde | C10H9NO | M−H | 1.77 | 158.06 | 2.30 | BMDB01190 | 1.19 |
| Hyodeoxycholic acid | C24H40O4 | M−H | 8.95 | 391.29 | 2.24 | BMDB00733 | −1.92 |
| 13-L-Hydroperoxylinoleic acid | C18H32O4 | M−H | 6.94 | 311.22 | 0.37 | BMDB03871 | −1.29 |
| 9-OxoODE | C18H30O3 | M−H | 1.96 | 293.21 | 0.87 | BMDB04669 | −1.30 |
| Prostaglandin F2a | C20H34O5 | M−H | 8.15 | 353.23 | 1.24 | BMDB01139 | −1.40 |
| 4-Fumarylacetoacetic acid | C8H8O6 | M−H | 8.73 | 199.03 | 1.54 | BMDB01268 | −1.30 |
| 5-L-Glutamyl-taurine | C7H14N2O6S | M−H | 1.31 | 253.04 | 2.36 | BMDB04195 | 1.36 |
| D-Erythrose 4-phosphate | C4H9O7P | M−H | 11.41 | 199.00 | 1.36 | BMDB01321 | 1.32 |
| L-Tyrosine | C9H11NO3 | M+H | 12.58 | 182.08 | 1.95 | BMDB00158 | 1.26 |
| LysoPE(0:0/15:0) | C20H42NO7P | M−H | 9.73 | 438.26 | 4.84 | BMDB11502 | −1.25 |
| Phenylpyruvic acid | C9H8O3 | M−H | 1.19 | 163.04 | 2.23 | BMDB00205 | 1.14 |
| PIP2(16:0/16:1(9Z)) | C41H79O19P3 | M+H | 11.23 | 969.46 | 4.95 | BMDB10033 | −1.22 |
UPLC-qTOF metabolites identified (P < 0.1), RT, retention time; ID, identification matched from bovine metabolome database matched, fold changes comparing high-ADG vs. low-ADG steers.
Figure 1Ruminal metabolomic profile of the steers with the greatest average daily gain (high-ADG; open red triangle) and the least ADG (low-ADG; green plus) with similar average dry matter intake. (A) Principal component analysis for UPLC-qTOF 90 metabolites identified to differ between ADG by t-test (P < 0.1). (B) Partial Least Square-Discriminant Analysis for UPLC-qTOF 90 metabolites identified to differ between ADG by t-test (P < 0.1). One data point represents one steer.
Figure 2Ruminal metabolomics pathway analysis by MetaboAnalyst 3.0 Software on the steers with the greatest average daily gain compare to the least ADG with similar average dry matter intake according to Bos taurus KEGG pathway database. UPLC-qTOF 90 metabolites identified to differ between ADG by t-test (P < 0.1). (a) Alpha-linolenic acid metabolism, (b) linoleic metabolism (c) taurine and hypotaurine metabolism d) phenylalanine, tyrosine and tryptophan (e) sphingolipids (f) phenylalanine (g) retinol (h) histidine (i) primary bile biosynthesis (j) glycerophospholipid (k) tyrosin (l) porphyrin and chlorophyll (m) steroid hormone biosynthesis (n) glutathione (o) Riboflavin (p) Gluconeogenesis. The darker the color and larger the size represent higher P-value from enrichment analysis and greater impact from the pathway topology analysis, respectively.
Figure 3The integrative ruminal metabolic pathway changes on the steers with the greatest average daily gain compare to the least ADG with similar average dry matter intake according to Bos taurus KEGG pathway database. UPLC-qTOF 90 metabolites identified to differ between ADG by t-test (P < 0.1).
Result from ruminal fluid pathway analysis.
| Metabolic pathway | Total Cmpd | Hits |
| −log(p) | Impact |
|---|---|---|---|---|---|
| Biosynthesis of unsaturated fatty acids | 42 | 4 | 0.01 | 4.58 | 0.00 |
| Primary bile acid biosynthesis | 46 | 2 | 0.01 | 4.28 | 0.06 |
| Riboflavin metabolism | 11 | 1 | 0.02 | 4.06 | 0.00 |
| Glutathione metabolism | 26 | 1 | 0.02 | 3.73 | 0.01 |
| Histidine metabolism | 14 | 2 | 0.03 | 3.62 | 0.14 |
| Porphyrin and chlorophyll metabolism | 25 | 1 | 0.03 | 3.36 | 0.06 |
| Pentose phosphate pathway | 19 | 1 | 0.04 | 3.35 | 0.00 |
| alpha-Linolenic acid metabolism | 9 | 2 | 0.04 | 3.29 | 1.00 |
| Amino sugar and nucleotide sugar metabolism | 37 | 1 | 0.04 | 3.24 | 0.00 |
| Steroid hormone biosynthesis | 67 | 2 | 0.04 | 3.19 | 0.06 |
| Linoleic acid metabolism | 5 | 2 | 0.05 | 3.03 | 1.00 |
| Taurine and hypotaurine metabolism | 7 | 1 | 0.07 | 2.61 | 0.75 |
| Sphingolipid metabolism | 21 | 1 | 0.08 | 2.54 | 0.28 |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 4 | 2 | 0.08 | 2.47 | 0.50 |
| Phenylalanine metabolism | 9 | 2 | 0.08 | 2.47 | 0.24 |
| Glycolysis or Gluconeogenesis | 26 | 1 | 0.10 | 2.35 | 0.00 |
| Pyruvate metabolism | 22 | 1 | 0.10 | 2.35 | 0.00 |
| Retinol metabolism | 17 | 1 | 0.10 | 2.33 | 0.22 |
| Arginine and proline metabolism | 44 | 1 | 0.12 | 2.11 | 0.00 |
| Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 14 | 1 | 0.13 | 2.08 | 0.02 |
| Glycerophospholipid metabolism | 29 | 2 | 0.13 | 2.02 | 0.14 |
| Tyrosine metabolism | 42 | 2 | 0.16 | 1.82 | 0.15 |
| Tryptophan metabolism | 41 | 2 | 0.17 | 1.79 | 0.08 |
| Ubiquinone and other terpenoid-quinone biosynthesis | 3 | 1 | 0.27 | 1.29 | 0.00 |
| Aminoacyl-tRNA biosynthesis | 64 | 1 | 0.27 | 1.29 | 0.00 |
| Arachidonic acid metabolism | 36 | 1 | 0.31 | 1.18 | 0.00 |
Total Cmpd = Total is the total number of compounds in the pathway; Hits is the actually matched number from the user uploaded data; P is the original P-value calculated from the enrichment analysis; Impact is the pathway impact value calculated from pathway topology analysis.
Identification of candidate biomarkers for feed efficiency on ruminal fluid.
| Identified metabolite | Formula | Adducts | RT (min) | Ion (m/z) | Mass error (ppm) | VIP | Fold change | AUC |
| FDR |
|---|---|---|---|---|---|---|---|---|---|---|
| Alloxan | C4H2N2O4 | M−H | 15.87 | 140.99 | 1.97 | 1.01 | 1.27 | 0.89 | <0.01 | 0.047 |
| 12,13-DHOME | C18H34O4 | M−H | 10.17 | 313.24 | 1.47 | 0.92 | −1.43 | 0.89 | <0.01 | 0.047 |
| Kynurenic acid | C10H7NO3 | M−H | 2.19 | 188.03 | 3.25 | 1.86 | −1.96 | 0.89 | 0.01 | 0.047 |
| Tauroursodeoxycholic acid | C26H45NO6S | M−H | 1.80 | 498.29 | 0.73 | 2.51 | −6.74 | 0.84 | 0.01 | 0.047 |
| Celastrol | C29H38O4 | M−H | 12.29 | 449.27 | 2.25 | 0.71 | 1.40 | 0.89 | 0.01 | 0.047 |
| DG(22:0/20:3(5Z,8Z,11Z)/0:0) | C45H82O5 | M + H | 14.63 | 703.62 | 3.66 | 1.57 | 2.02 | 0.86 | 0.01 | 0.047 |
| Pentadecanoic acid2 | C15H30O2 | M−H | 13.03 | 241.22 | 1.06 | 1.26 | −1.70 | 0.86 | 0.01 | 0.047 |
| Malonyl-L-carnitine | C10H17NO6 | M−H | 1.95 | 246.10 | 0.40 | 1.05 | 1.30 | 0.86 | 0.01 | 0.047 |
| Pterin | C6H5N5O | M−H | 13.03 | 162.04 | 2.64 | 1.24 | 1.48 | 0.84 | 0.02 | 0.047 |
| N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole | C14H19N2O7P | M + H | 8.67 | 359.09 | 2.19 | 0.67 | 1.76 | 0.86 | 0.02 | 0.047 |
| Pteroyl-D-glutamic acid | C20H23N7O7 | M + H | 10.78 | 474.17 | 1.47 | 0.70 | 1.17 | 0.83 | 0.02 | 0.047 |
| N-Acryloylglycine | C5H7NO3 | M + H | 12.40 | 130.05 | 4.82 | 0.67 | 1.13 | 0.84 | 0.02 | 0.047 |
| Eicosenoic acid2 | C20H38O2 | M−H | 14.59 | 309.28 | 0.99 | 1.00 | −1.62 | 0.81 | 0.02 | 0.047 |
| Pyroglutamic acid | C5H7NO3 | M−H | 13.28 | 128.03 | 4.73 | 1.43 | 1.62 | 0.86 | 0.02 | 0.047 |
| All-trans-heptaprenyl diphosphate | C28H49N3O16 | M + H | 10.46 | 655.38 | 3.81 | 1.31 | −1.51 | 0.83 | 0.03 | 0.047 |
| 5-Dodecenoic acid | C12H22O2 | M + H | 10.35 | 199.17 | 4.97 | 0.97 | −1.38 | 0.80 | 0.03 | 0.047 |
| 3-Oxooctadecanoic acid | C18H34O3 | M + H | 10.35 | 299.26 | 2.80 | 0.82 | −1.33 | 0.81 | 0.03 | 0.047 |
| Androsterone sulfate | C19H30O5S | M + H | 8.67 | 371.19 | 2.75 | 0.86 | 1.23 | 0.83 | 0.03 | 0.047 |
| DG(18:3(9Z,12Z,15Z)/15:0/0:0) | C36H64O5 | M + H | 17.45 | 577.48 | 4.31 | 1.04 | 1.43 | 0.88 | 0.03 | 0.047 |
| Linoleic acid* | C18H32O2 | M + H | 10.35 | 281.25 | 2.59 | 0.97 | −1.21 | 0.81 | 0.03 | 0.047 |
| 20-Carboxyleukotriene B4 | C20H30O6 | M + H | 14.26 | 367.21 | 1.21 | 0.75 | −1.14 | 0.75 | 0.03 | 0.047 |
| Harderoporphyrin | C35H36N4O6 | M + H | 12.11 | 609.27 | 3.55 | 1.71 | −2.56 | 0.78 | 0.03 | 0.047 |
| Sebacic acid | C10H18O4 | M−H | 7.31 | 201.11 | 2.59 | 0.74 | 1.38 | 0.80 | 0.03 | 0.047 |
| Oleamide | C18H35NO | M + H | 15.07 | 282.28 | 3.66 | 0.64 | 1.13 | 0.83 | 0.04 | 0.047 |
| Glycocholic acid | C26H43NO6 | M−H | 5.52 | 464.30 | 0.96 | 1.86 | −1.94 | 0.78 | 0.04 | 0.047 |
| Chitin | C28H49N3O16 | M + H | 10.57 | 684.32 | 3.56 | 0.63 | 1.41 | 0.80 | 0.04 | 0.047 |
| Imidazole-4-acetaldehyde | C5H6N2O | M−H | 1.36 | 109.04 | 3.19 | 0.62 | 1.13 | 0.79 | 0.04 | 0.047 |
| Vaccenic acid | C18H34O2 | M−H | 13.39 | 281.25 | 0.16 | 1.01 | −1.37 | 0.80 | 0.04 | 0.047 |
| Calcitroic acid | C23H34O4 | M + H | 11.20 | 375.25 | 2.29 | 0.56 | 1.13 | 0.80 | 0.04 | 0.047 |
| Alpha-Linolenic acid2 | C18H30O2 | M + H | 9.80 | 279.23 | 1.08 | 1.09 | −2.23 | 0.80 | 0.04 | 0.047 |
| 12a-Hydroxy-3-oxo-choladienic acid | C24H34O4 | M−H | 11.59 | 385.24 | 1.49 | 1.26 | −1.35 | 0.83 | 0.04 | 0.047 |
| 5-Sulfosalicylic acid | C7H6O6S | M + H | 13.46 | 219.00 | 1.77 | 1.14 | 1.51 | 0.75 | 0.05 | 0.049 |
| 3-Octenedioic acid | C8H12O4 | M−H | 9.52 | 171.07 | 2.13 | 1.05 | 1.50 | 0.77 | 0.05 | 0.049 |
RT, retention time; VIP, value of importance in projection; Fold changes comparing the greatest average daily gain steers (n = 8) with the least average daily gain steers (n = 8) on ruminal fluid metabolites; AUC, area under the curve; P, treatment effect result from t-test; FDR, false discovery rate p-adjustment.
2Metabolites were quantified by liquid chromatogram tandem mass spectrometry using isotope dilution.
Fatty acid concentrations in ruminal fluid on steers with the least and greatest average daily gain.
| Fatty acids (µg/mL) | Group1 | SEM | AUC2 |
| FDR3 | |
|---|---|---|---|---|---|---|
| Least-ADG | Greatest-ADG | |||||
| Pentadecanoic acid (C15:0) | 1.94 | 1.41 | 0.04 | 0.91 | <0.01 | 0.01 |
| Palmitic acid (C16:0) | 245.5 | 224.1 | 6.65 | 0.70 | 0.13 | 0.17 |
| Linoleic acid (C18:2) | 28.07 | 19.19 | 2.56 | 0.75 | 0.10 | 0.14 |
| Alpha-Linolenic acid (C18:3) | 0.023 | 0.015 | 0.002 | 0.85 | 0.02 | 0.08 |
| Eicosanoic acid (C20:0) | 15.51 | 13.34 | 1.06 | 0.77 | 0.16 | 0.19 |
1Groups were least-ADG steers (n = 8), with the least average daily gain and greatest-ADG steers (n = 8), with the greatest average daily gain, with groups having similar dry matter intake. 2AUC = area under the curve calculated by receiver-operator characteristic curve analysis. 3FDR = False discovery rate p-adjustment.
Fatty acid concentrations in plasma on steers with the least and greatest average daily gain.
| Fatty acids (µg/mL) | Group1 | SEM | AUC2 |
| FDR3 | |
|---|---|---|---|---|---|---|
| Least-ADG | Greatest-ADG | |||||
| Pentadecanoic acid (C15:0) | 0.575 | 0.573 | 0.394 | 0.53 | 0.53 | 0.53 |
| Palmitic acid (C16:0) | 11.34 | 10.95 | 1.007 | 0.62 | 0.78 | 0.78 |
| Stearic acid (C18:0) | 10.21 | 8.230 | 0.575 | 0.80 | 0.03 | 0.08 |
| Linoleic acid (C18:2) | 2.511 | 2.112 | 0.386 | 0.56 | 0.48 | 0.48 |
| Alpha-linolenic acid (C18:3) | 0.037 | 0.032 | 0.002 | 0.73 | 0.09 | 0.14 |
| Eicosanoic acid (C20:0) | 0.117 | 0.209 | 0.058 | 0.62 | 0.82 | 0.82 |
| Arachidonic acid (C20:4) | 0.251 | 0.170 | 0.085 | 0.84 | 0.06 | 0.10 |
| Docosahexaenoic acid (C22:6n3) | 0.025 | 0.020 | 0.002 | 0.65 | 0.20 | 0.24 |
1Groups were least-ADG steers (n = 8), with the least average daily gain, and greatest-ADG steers (n = 8), with the greatest average daily gain, with groups having similar dry matter intake. 2AUC = area under the curve calculated by receiver-operator characteristic curve analysis. 3FDR = false discovery rate p-adjustment.
Figure 4Receiver operating curves (ROC) of fatty acids for the differential identification of feed efficiency on steers. (A) Rumen fluid ROC using the combination of pentadecanoic acid, palmitic acid, linoleic acid and alpha-linolenic acid. (B) Plasma ROC using the combination of arachidonic acid/docosahexanoic acid ratio and alpha-linolenic acid.
Figure 5Overview of workflow utilized in the identification of biomarkers of feed efficiency on crossbreed steers.
Figure 6Rumen sampling selection. The two animals groups were selected by the greatest average daily gain (high-ADG; open red triangle; n = 8) and the least ADG steers (low-ADG; green plus; n = 8) with similar average dry matter intake (dash line) from the total population (black dots; n = 144) evaluated.